BridgeMD
New treatment option for Glucose Metabolism Disorders (Including Diabetes Mellitus)
Official title The Role of Oxytocin in Regulating Blood Glucose
ClinicalTrials.gov ID: NCT06334172
What this study is testing
What is Oxytocin?
Oxytocin is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for glucose metabolism disorders (including diabetes mellitus).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Investigating the effect of oxytocin on pancreatic endocrine functions by determining insulin and glucagon secretion within physiological ranges of plasma glucose.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 50, men only
You may be able to join if
- BMI 19-25 kg/m2
You likely can't join if
- Diabetes
- Heart-, liver or kidney disease
- More than 14 units of alcohol weekly, or drug abuse
- Smoking or any kind of nicotine products
- Alanin aminotransferase (ALAT) ≥ 2 × normal range
- Estimated glomerular filtration rate (eGFR) \< 60 ml/min/1,73m2 or creatinine above normal range
See the full eligibility criteria
- BMI 19-25 kg/m2
- Diabetes
- Heart-, liver or kidney disease
- More than 14 units of alcohol weekly, or drug abuse
- Smoking or any kind of nicotine products
- Alanin aminotransferase (ALAT) ≥ 2 × normal range
- Estimated glomerular filtration rate (eGFR) \< 60 ml/min/1,73m2 or creatinine above normal range
- Blood pressure \> 140/90
- Hemoglobin \< normal range
- Corrected QT Interval (Qtc) \>0,45 sec. at electrocardiogram (ECG) at screening
- Known disease in the pituitary gland or previous pituitary surgery
- Any other disease/condition which the trial managers believe may affect participation in the trial
The study team makes the final eligibility decision.
Where it's taking place
- Hellerup, Capital Region, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 20 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hellerup, Capital Region, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.